Victory Capital Management
BEAM icon

Victory Capital Management’s Beam Therapeutics BEAM Stock Holding History

Victory Capital Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$741K Buy
31,099
+117
+0.4% +$3.25K ﹤0.01% 1943
2025
Q4 		$859K Buy
30,982
+106
+0.3% +$2.7K ﹤0.01% 1897
2025
Q3 		$749K Sell
30,876
-167
-0.5% -$3.32K ﹤0.01% 1962
2025
Q2 		$528K Buy
31,043
+20,431
+193% +$356K ﹤0.01% 2050
2025
Q1 		$207K Buy
10,612
+1,618
+18% +$42.4K ﹤0.01% 2213
2024
Q4 		$223K Sell
8,994
-99
-1% -$2.53K ﹤0.01% 2207
2024
Q3 		$223K Sell
9,093
-828
-8% -$21.4K ﹤0.01% 2201
2024
Q2 		$232K Buy
9,921
+973
+11% +$23.9K ﹤0.01% 2164
2024
Q1 		$296K Sell
8,948
-334
-4% -$10.4K ﹤0.01% 2123
2023
Q4 		$253K Buy
+9,282
New +$231K ﹤0.01% 2174
2023
Q3 		– Sell
-21,483
Closed -$686K – 2521
2023
Q2 		$686K Sell
21,483
-151
-0.7% -$4.9K ﹤0.01% 1847
2023
Q1 		$662K Buy
21,634
+1,677
+8% +$66.2K ﹤0.01% 1895
2022
Q4 		$781K Sell
19,957
-1,236
-6% -$55.4K ﹤0.01% 1847
2022
Q3 		$1.01M Sell
21,193
-384
-2% -$21.9K ﹤0.01% 1729
2022
Q2 		$835K Sell
21,577
-663,609
-97% -$26.4M ﹤0.01% 1826
2022
Q1 		$38.8M Buy
685,186
+107,516
+19% +$7.05M 0.04% 629
2021
Q4 		$46M Sell
577,670
-120,209
-17% -$10.3M 0.04% 590
2021
Q3 		$60.7M Buy
697,879
+163,750
+31% +$16.5M 0.06% 460
2021
Q2 		$68.7M Sell
534,129
-59,476
-10% -$4.74M 0.07% 420
2021
Q1 		$47.5M Buy
593,605
+515,886
+664% +$49.1M 0.05% 566
2020
Q4 		$6.34M Sell
77,719
-22,022
-22% -$1.08M 0.01% 1180
2020
Q3 		$2.46M Sell
99,741
-18,437
-16% -$457K ﹤0.01% 1385
2020
Q2 		$3.31M Sell
118,178
-411,564
-78% -$8.87M ﹤0.01% 1276
2020
Q1 		$9.54M Buy
+529,742
New +$11.5M 0.01% 1099

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Victory Capital Management's BEAM Position: Q1 2026 in Review

Victory Capital Management increased its Beam Therapeutics (BEAM) stake by 0.38% in Q1 2026, buying an estimated $3.25K and bringing the position to 31,099 shares worth $741K. The position accounts for ﹤0.01% of the portfolio, ranked #1943.

Victory Capital Management first reported a position in BEAM in Q1 2020 and has held it in 24 quarters since. The position peaked at $68.7M in Q2 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Victory Capital Management held 31,099 shares of Beam Therapeutics worth $741K as of Q1 2026.
  • Victory Capital Management bought 117 Beam Therapeutics shares in Q1 2026, an estimated $3.25K.
  • Beam Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #1943 holding.
  • Victory Capital Management first reported a position in Beam Therapeutics in Q1 2020 and has held it in 24 quarters since.
  • Victory Capital Management's Beam Therapeutics position peaked at $68.7M in Q2 2021.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.